Enlivex (ENLV) has released an update. Enlivex Therapeutics has commenced the next phase of its Allocetra trial, enrolling and dosing the first ...

Researchers have developed a non-addictive painkiller that remains inactive until it reaches sites of chronic pain. Instead of dulling the nerves that send the pain signals like other analgesics, this ...

One of three patients in Cohort 5 achieved complete histological remission at 12 weeks. <li /> Consistent improve ...

The drug semaglutide, commonly known by the brand names Ozempic or Wegovy, was originally developed to help people with type 2 diabetes manage their ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

The findings offer promising support for progressing ADPO-002NP treatment to first-in-human Phase I clinical trials. Adipo ...

ATLANTA, GA / ACCESSWIRE / November 12, 2024 / The Arthritis Foundation welcomes Zoetis, maker of innovative therapies for osteoarthritis pain in pets, as the two-year National Presenting Sponsor of ...

Genascence Corporation ("Genascence"), a clinical-stage biotechnology company revolutionizing the treatment of prevalent ...

The cell-free cartilage repair market in the United States is projected to grow at a CAGR of 4% during the assessment period.

Weight loss drugs like Ozempic and Wegovy may provide strong relief from severe osteoarthritis knee pain, new research finds.